The European Journal of Health Economics This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
ConclusionsEmpagliflozin added to SoC leads to health benefits for patients with HFrEF and is a cost-effective treatment option for payers in multiple European countries (UK, Spain, France). (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - December 4, 2022 Category: Health Management Source Type: research

Social costs of obesity in the Czech Republic
This article demonstrates that obesity is a serious problem with considerable costs. Several preventive interventions should be applied in order to decrease the prevalence of obesity and achieve cost savings. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - November 30, 2022 Category: Health Management Source Type: research

Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer ´s patients: a Finnish nationwide register study
ConclusionsEarly diagnosis and start of anti-dementia medication is important for managing the costs of increasing number of AD patients. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - November 30, 2022 Category: Health Management Source Type: research

Public preferences for policies promoting a healthy diet: a discrete choice experiment
ConclusionPreferences for policies promoting a healthy diet vary considerably in the Dutch population, particularly in relation to more intrusive policies. This makes selection and implementation of a policy package that has wide public support challenging. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - November 29, 2022 Category: Health Management Source Type: research

Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries
AbstractMost countries that apply risk-equalization in their health insurance market(s) perform risk-equalization on medical claims but do not include other components of the insurance premium, such as administrative costs. Using fixed effects panel regressions from individual insurers in Australia, Germany, the Netherlands, Switzerland, and the US, we find evidence that health insurers with a high morbidity population on average have higher administrative costs. We argue that administrative costs should also be included in risk-equalization and we show that such equalization results in additional equalization payments non...
Source: The European Journal of Health Economics - November 23, 2022 Category: Health Management Source Type: research

Excess costs of multiple sclerosis: a register-based study in Sweden
ConclusionsThe socioeconomic burden of MS in Sweden from healthcare consumption and productivity losses was quantified, updating knowledge on the cost structure of the substantial excess costs of MS. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - November 23, 2022 Category: Health Management Source Type: research

EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy
ConclusionsThis study is the first to investigate the HRQoL of patients with SBMA worldwide. The estimated health utility scores for EQ-5D and SF-6D can be utilized as baseline data for future cost-utility analyses of SBMA-related interventions. (Source: The European Journal of Health Economics)
Source: The European Journal of Health Economics - November 23, 2022 Category: Health Management Source Type: research

Out-of-pocket costs sustained in the last 12 months by cancer patients: an Italian survey-based study on individual expenses between 2017 and 2018
ConclusionItalian cancer patients in 2018 sustained OOP quite similar to those measured in 2012 to supplement NHS services. The main component of the OOP costs were diagnostic examination and transportation. The NHS should pay attention to potentiate its ability to answer unmet needs of patients with advanced cancer who are the most fragile ones.Implications for cancer survivorsReinforcing the services where the main OOP expenses are located can help in promoting public health actions and reduce socio-economic needs that could compromise the receipt of optimal care along the whole disease course, from diagnosis to rehabili...
Source: The European Journal of Health Economics - November 22, 2022 Category: Health Management Source Type: research